6.87SAR
892.62 MSAR
8.71 BSAR
84.50 M
About NAHDI MEDICAL CO.
Sector
Industry
CEO
Yasser Ghulam Abdulaziz Joharji
Website
Headquarters
Jeddah
Founded
1986
ISIN
SA15HG521213
FIGI
BBG015JNKR59
Nahdi Medical Co. engages in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy food, and medical equipment. It operates through the following segments: Front Shop, Pharma, and Others. The company was founded by Abdullah Amer Al Nahdi on June 18, 1986 and is headquartered in Jeddah, Saudi Arabia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4164 is 140.20 SAR — it has decreased by 0.57% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TADAWUL exchange NAHDI MEDICAL CO. stocks are traded under the ticker 4164.
NAHDI MEDICAL CO. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
4164 stock is 1.43% volatile and has beta coefficient of 0.62. Check out the list of the most volatile stocks — is NAHDI MEDICAL CO. there?
One year price forecast for NAHDI MEDICAL CO. has a max estimate of 200.00 SAR and a min estimate of 134.00 SAR.
NAHDI MEDICAL CO. revenue for the last quarter amounts to 2.24 B SAR despite the estimated figure of 2.19 B SAR. In the next quarter revenue is expected to reach 2.20 B SAR.
Yes, you can track NAHDI MEDICAL CO. financials in yearly and quarterly reports right on TradingView.
4164 stock has fallen by 3.97% compared to the previous week, the month change is a 6.16% fall, over the last year NAHDI MEDICAL CO. has showed a 20.43% decrease.
4164 net income for the last quarter is 170.52 M SAR, while the quarter before that showed 212.81 M SAR of net income which accounts for −19.87% change. Track more NAHDI MEDICAL CO. financial stats to get the full picture.
Today NAHDI MEDICAL CO. has the market capitalization of 18.33 B, it has decreased by 0.14% over the last week.
NAHDI MEDICAL CO. dividend yield was 4.01% in 2023, and payout ratio reached 80.10%. The year before the numbers were 3.18% and 77.75% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 4164 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NAHDI MEDICAL CO. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NAHDI MEDICAL CO. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NAHDI MEDICAL CO. stock shows the strong sell signal. See more of NAHDI MEDICAL CO. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on NAHDI MEDICAL CO. future price: according to them, 4164 price has a max estimate of 200.00 SAR and a min estimate of 134.00 SAR. Read a more detailed NAHDI MEDICAL CO. forecast: see what analysts think of NAHDI MEDICAL CO. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NAHDI MEDICAL CO. EBITDA is 1.56 B SAR, and current EBITDA margin is 18.05%. See more stats in NAHDI MEDICAL CO. financial statements.